בוקולאם 5 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

MIDAZOLAM AS HYDROCHLORIDE 5 MG

Disponible desde:

NEOPHARM CURE (2005) LTD

Código ATC:

N05CD08

formulario farmacéutico:

OROMUCOSAL SOLUTION

Vía de administración:

BUCCAL

Fabricado por:

SCM PHARMA LIMITED, UK

Grupo terapéutico:

MIDAZOLAM

indicaciones terapéuticas:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Fecha de autorización:

2013-05-01